This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • Uncategorised Disease
  • /
  • Inhibiting COMT in Parkinson's Disease
Clinical trial

Inhibiting COMT in Parkinson's Disease

Read time: 1 mins
Last updated:18th Feb 2014

The overall aim of this observational study is to investigate the impact of COMT inhibition on homocysteine metabolism, vascular physiology and correlates of neurodegeneration in PD patients with certain COMT genotype. It is designed to evaluate effect size of Hcy lowering to secondary outcome parameters. Assessment of outcome parameters will be rater-blinded or computer-based.

Category Value
Study start date 2014-02-18

View full details